Reproducibility of Heart Rate Variability Indices in Children with Cystic Fibrosis.

about

Reproducibility of 24-h heart rate variability in children.

P2860

Q47968642-F7F3988A-0203-43FC-A654-6B367403EC6D

P2860

Reproducibility of Heart Rate Variability Indices in Children with Cystic Fibrosis.

Item

http://www.wikidata.org/entity/Q35954257

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Reproducibility of Heart Rate Variability Indices in Children with Cystic Fibrosis.

@ast

Reproducibility of Heart Rate Variability Indices in Children with Cystic Fibrosis.

@en

type

Item

label

Reproducibility of Heart Rate Variability Indices in Children with Cystic Fibrosis.

@ast

Reproducibility of Heart Rate Variability Indices in Children with Cystic Fibrosis.

@en

prefLabel

Reproducibility of Heart Rate Variability Indices in Children with Cystic Fibrosis.

@ast

Reproducibility of Heart Rate Variability Indices in Children with Cystic Fibrosis.

@en

P1476

Reproducibility of Heart Rate Variability Indices in Children with Cystic Fibrosis.

@en

P2860

Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology

Quality control methods in accelerometer data processing: defining minimum wear time

Imputation of missing data when measuring physical activity by accelerometry.

Decreased heart rate variability and its association with increased mortality after acute myocardial infarction.

Decreased adenosine 3':5'-monophosphate response to isoproterenol in cystic fibrosis leukocytes.

Frequency domain measures of heart period variability and mortality after myocardial infarction.

Calibration of two objective measures of physical activity for children.

Heart rate variability in patients with ventricular arrhythmias: effect of antiarrhythmic drugs. Antiarrhythmic Drug Evaluation Group (ADEG).

Heart rate variability at rest and after the 6-minute walk test (6MWT) in children with cystic fibrosis.

Reliability of three commercially available heart rate variability instruments using short-term (5-min) recordings.

P304

e0151464

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0151464

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kelly A Mackintosh

Melitta A McNarry

P577

2016-03-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

297890798

http://www.w3.org/2001/XMLSchema#string

P698

26968039

http://www.w3.org/2001/XMLSchema#string

P921

reproducibility

cystic fibrosis

heart rate variability

P932

4788309

http://www.w3.org/2001/XMLSchema#string

Reproducibility of Heart Rate Variability Indices in Children with Cystic Fibrosis.

about

P2860

P2860

Reproducibility of Heart Rate Variability Indices in Children with Cystic Fibrosis.

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932